| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.1 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.069 | 0.1 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | 0.23 | 0.2 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |